Blue Earth Ther­a­peu­tics snags $76M for both al­pha and be­ta ra­dio­ther­a­pies

The ra­dio­phar­ma field con­tin­ues to buzz with pri­vate fi­nanc­ings and more clin­i­cal-stage pro­grams.

The lat­est is Ox­ford, UK-based Blue Earth Ther­a­peu­tics, which un­veiled a …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER